Quotient Limited (QTNT)
| Market Cap | 442.66M |
| Revenue (ttm) | 43.38M |
| Net Income (ttm) | -108.47M |
| Shares Out | 101.53M |
| EPS (ttm) | -1.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 16 |
| Last Price | $4.21 |
| Previous Close | $4.26 |
| Change ($) | -0.05 |
| Change (%) | -1.17% |
| Day's Open | 4.24 |
| Day's Range | 4.17 - 4.29 |
| Day's Volume | 40,240 |
| 52-Week Range | 3.41 - 8.77 |
Shares pulled back after surging earlier in the year.
JERSEY, Channel Islands, June 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today r...
JERSEY, Channel Islands, May 31, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the management team will participate in two upcoming inv...
JERSEY, Channel Islands, May 24, 2021 (GLOBE NEWSWIRE) -- Quotient Limited ("Quotient") (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that it has agreed to sell $95.0 million a...
JERSEY, Channel Islands, April 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the company has been recognized wit...
JERSEY, Channel Islands, April 05, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported encouraging result from a study of its Mo...
JERSEY, Channel Islands, March 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to ...
JERSEY, Channel Islands, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that Manuel Mendez has been appointed as ...
JERSEY, Channel Islands, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today ...
Quotient Limited (QTNT) CEO Franz Walt on Q3 2021 Results - Earnings Call Transcript
Quotient (QTNT) delivered earnings and revenue surprises of -11.54% and 4.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Quotient (NASDAQ:QTNT) moved higher by 1.2% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 21.62% year over year to ($0.29), which we...
JERSEY, Channel Islands, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today ...
On Monday, February 01, Quotient (NASDAQ:QTNT) will release its latest earnings report. Decipher the announcement with Benzinga's help.
Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JERSEY, Channel Islands, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has been named a winner in the prestig...
JERSEY, Channel Islands, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that on December 21, 2020, Ed Farrell del...
JERSEY, Channel Islands, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that it received a request from the U.S. ...
JERSEY, Channel Islands, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported preliminary EU field trial performance dat...
Quotient Limited (QTNT) CEO Franz Walt on Q2 2021 Results - Earnings Call Transcript
Quotient (QTNT) delivered earnings and revenue surprises of 48.57% and 105.97%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
JERSEY, Channel Islands, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today ...
Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JERSEY, Channel Islands, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter en...
JERSEY, Channel Islands, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S. Food and Drug Adm...
JERSEY, Channel Islands, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced the closing of its previously annou...
JERSEY, Channel Islands, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the Company), a commercial-stage diagnostics company, today announced the upsize and pricing of a $75 milli...
JERSEY, Channel Islands, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an un...
JERSEY, Channel Islands, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that the Company and Ortho Clinical Diagnostics (Ortho...
JERSEY, Channel Islands, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Bloodworks Northwest is now offering all blood donors across the Pacific Northwest free COVID-19 antibody testing with the possibility of dis...
JERSEY, Channel Islands, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the ...
Quotient Limited (QTNT) CEO Franz Walt on Q1 2021 Results - Earnings Call Transcript
Shares of Quotient (NASDAQ:QTNT) remained unaffected after the company reported Q1 results.
Quotient (QTNT) delivered earnings and revenue surprises of 3.03% and 4.99%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
JERSEY, Channel Islands, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, toda...
JERSEY, Channel Islands, July 23, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced th...
JERSEY, Channel Islands, July 23, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced c...
JERSEY, Channel Islands, July 20, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported th...
JERSEY, Channel Islands, July 17, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter e...
Quotient Limited (QTNT) CEO Franz Walt on Q4 2020 Results - Earnings Call Transcript
Shares of Quotient (NASDAQ:QTNT) were unchanged in pre-market trading after the company reported Q4 results.
JERSEY, Channel Islands, June 09, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today...
Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JERSEY, Channel Islands, May 11, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, and hVIVO, part of Open Orphan p...
JERSEY, Channel Islands, May 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced th...
JERSEY, Channel Islands, April 27, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported v...
JERSEY, Channel Islands, April 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported p...
Quotient (NASDAQ: QTNT) shares are trading higher on Monday, after the company announced the completion of its coronavirus antibodies test development.
JERSEY, Channel Islands, April 06, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced ...
JERSEY, Channel Islands, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported po...
About QTNT
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, w... [Read more...]
| Industry Diagnostics & Research | IPO Date Apr 25, 2014 |
| CEO Franz Walt | Employees 435 |
| Stock Exchange NASDAQ | Ticker Symbol QTNT |
Financial Performance
In 2020, Quotient's revenue was $43.38 million, an increase of 32.84% compared to the previous year's $32.66 million. Losses were -$108.47 million, 5.54% more than in 2019.
Analyst Forecasts
According to 3 analysts, the average rating for Quotient stock is "Strong Buy." The 12-month stock price forecast is 10.50, which is an increase of 149.41% from the latest price.